134 related articles for article (PubMed ID: 21306285)
1. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.
Zamorano J; Erdine S; Pavia A; Kim JH; Al-Khadra A; Westergaard M; Sutradhar S; Yunis C;
Curr Med Res Opin; 2011 Apr; 27(4):821-33. PubMed ID: 21306285
[TBL] [Abstract][Full Text] [Related]
2. Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial.
Hradec J; Zamorano J; Sutradhar S
Curr Med Res Opin; 2013 Jun; 29(6):589-96. PubMed ID: 23464930
[TBL] [Abstract][Full Text] [Related]
3. Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial.
Pavia A; Zamorano J; Sutradhar S; Yunis C;
Curr Med Res Opin; 2012 Oct; 28(10):1667-76. PubMed ID: 22991979
[TBL] [Abstract][Full Text] [Related]
4. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
[TBL] [Abstract][Full Text] [Related]
5. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
Cowie MR
Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
[TBL] [Abstract][Full Text] [Related]
7. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
8. Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.
Kim JH; Zamorano J; Erdine S; Pavia A; Al-Khadra A; Sutradhar S; Yunis C;
Postgrad Med; 2012 Jul; 124(4):41-53. PubMed ID: 22913893
[TBL] [Abstract][Full Text] [Related]
9. Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial.
Kim JH; Zamorano J; Erdine S; Pavia A; Al-Khadra A; Sutradhar S; Yunis C;
Curr Med Res Opin; 2013 May; 29(5):453-63. PubMed ID: 23448581
[TBL] [Abstract][Full Text] [Related]
10. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
11. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
Cho EJ; Kim JH; Sutradhar S; Yunis C; Westergaard M;
Vasc Health Risk Manag; 2014; 10():145-56. PubMed ID: 24707184
[TBL] [Abstract][Full Text] [Related]
12. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
Grimm R; Malik M; Yunis C; Sutradhar S; Kursun A;
Vasc Health Risk Manag; 2010 May; 6():261-71. PubMed ID: 20479948
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
15. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
16. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
[TBL] [Abstract][Full Text] [Related]
17. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R; Hobbs FD; Zamorano J; Girerd X
Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
[TBL] [Abstract][Full Text] [Related]
18. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
[TBL] [Abstract][Full Text] [Related]
20. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
